I'm thrilled to sit down with Ivan Kairatov, a renowned expert in biopharma with a wealth of experience in research and development, particularly at the intersection of technology and innovation. Ivan has been deeply involved in groundbreaking advancements in the field, including the exploration of
Picture a scenario where a newborn’s routine liver test could instantly signal a rare genetic condition, slashing diagnostic delays and guiding medical teams toward the most effective care plan before irreversible damage sets in. This transformative possibility is becoming a reality with an
In a landscape where medical technology continues to evolve at a rapid pace, the latest quarterly earnings have revealed intriguing insights into the performance of companies within the imaging and diagnostics sector, set against a backdrop of mixed results and fluctuating investor confidence.
Neuroblastoma, recognized as one of the most devastating cancers affecting children, continues to challenge pediatric oncology with its alarmingly low survival rates for high-risk patients, which hover below 60%, making it a critical area of research. This aggressive tumor, frequently diagnosed in
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology and innovation within the healthcare industry. With a strong background in research and development, Ivan has been at the forefront of integrating cutting-edge solutions like artificial
The lab automation market is poised for a remarkable ascent, with forecasts projecting its value to soar to $12.5 billion by 2035, driven by a steady compound annual growth rate (CAGR) of 7.15% over the coming decade. This surge underscores a growing dependence on automated technologies to
